Clinical Trials in Philadelphia

Showing 6181-6200 of 20,904 trials

PArtial REbreathing for Migraine With Aura 1

NCT05546385

A prospective, multi-centre, randomized, double-blind, sham-controlled, parallel-group, group-sequential study to investigate safety and effectiveness of the Rehaler partial rebreathing device, in adults suffering from migraine with aura

Migraine With Aura

Rehaler142 participantsStarted Aug 2023

Palo Alto, California, United States • Pasadena, California, United States • Riverside, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

NCT03631784

This is a trial in adult participants with unresectable, locally advanced, Stage III non-small cell lung cancer (NSCLC) treated with pembrolizumab in combination with platinum doublet chemotherapy and standard thoracic radiotherapy followed by pembrolizumab monotherapy. The primary hypothesis of the trial is that within each platinum doublet chemotherapy cohort, the percentage of participants who develop Grade 3 or higher pneumonitis is ≤10% and estimation of objective response rate (ORR) by blinded independent central review (BICR).

Non-small Cell Lung Cancer

Merck Sharp & Dohme LLC216 participantsStarted Oct 2018

Santa Rosa, California, United States • Evanston, Illinois, United States • Fort Wayne, Indiana, United States +53 more locations

PArtial REbreathing for Migraine With Aura 1

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Find Trials by Condition in Philadelphia

Effects of Ketone Supplementation on Acute Alcohol Withdrawal

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

Heart Failure Optimization Study

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

SUBLOCADE Rapid Initiation Extension Study

SUBLOCADE Rapid Initiation Study

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

A Prospective Observational Study of TPIAT

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Urine CXCL10 Monitoring Trial in Kidney Transplant

A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects